Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
Recruiting · NCT07303387 · Registry updated 2026-04-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors. | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Phase 2 | 2026-04-21 | NCT07303387 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Daiichi Sankyo Co., Ltd. | 14 |
| Gustave Roussy, Cancer Campus, Grand Paris | 93 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Léon Berard | Lyon | France | 4 |
| Gustave Roussy | Villejuif | France | 17 |
| Institut Bergonié | Bordeaux | France | 53 |
| Institut Curie | Paris | France | 81 |